Yeastone Broth — Class II medical device recall Z-1806-2026
Ongoing recall by Remel, Inc, reported 2026-04-22, distributed nationwide. Products may report incorrect AST results during quality control. Health consequences may include delayed resp
| Recall number | Z-1806-2026 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Remel, Inc, Lenexa, KS, United States |
| Recall initiated | 2026-03-24 |
| Classified | 2026-04-10 |
| Reported by FDA | 2026-04-22 |
| Distributed | Nationwide (US) |
| Countries outside the US | AR, CA, FR, NL, NZ, QA, SG, TR, UY, VN |
| Quantity | 2,819 |
| UPC / GTIN / UDI-DI | 00848838018817 |
| Lot numbers | 303851, 311723, 321046, 327069, 329835, 330316, 330317, 336325, 338314, 341161 |
Product
Yeastone Broth, 11ML, 10/BOX YY3462
Reason for recall
Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1806-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.